RecruitingNot ApplicableNCT06497101

Effectiveness Trial of Temperament Based Therapy With Support (TBT-S)

Effectiveness of Temperament Based Therapy With Support (TBT-S): A Novel 5-day Treatment for Anorexia Nervosa


Sponsor

Oslo University Hospital

Enrollment

120 participants

Start Date

Nov 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The main aim of this project is to determine the short and long-term effectiveness of an out-patient treatment for patients with anorexia nervosa. Specifically, we will measure whether TBT-S in addition to treatment as usual (TAU) will be more effective than TAU alone in reducing eating disorder psychopathology. Assessments will be conducted at four timepoints; pre and post TBT-S, and at 3 and 12 months follow-up. Primary outcome measure is eating disorder psychopathology, with the hypothesis that patients receiving TBT-S in addition to TAU will show significantly greater reduction in eating disorder psychopathology from TBT-S treatment admission to 3 month follow-up, compared to controls.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥18, all genders
  • A Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosed anorexia nervosa disorder (F50.0, F50.01, F50.02, also including F50.9 - atypical anorexia nervosa)
  • Willingness to have Support(s) participate in treatment
  • Medically stable

Exclusion Criteria3

  • Intellectual developmental disorder or intellectual disability; psychotic disorder or other psychopathology that may affect or prevent participation in the study
  • diagnosed alcohol or other substance use disorder within 3 months prior to study initiation
  • ongoing inpatient treatment at the time of study enrollment (participants currently in inpatient care must be discharged and engaged in outpatient treatment before participating in the TBT-S week

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTemperament Based Therapy with Support (TBT-S)

Participants included in the intervention arm will receive TBT-S (5-day treatment) in addition to treatment as usual (TAU)


Locations(1)

Oslo University Hospital, Regional Department for Eating Disorders

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06497101


Related Trials